BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31140425)

  • 1. [Expression of NUF2 in breast cancer and its clinical significance].
    Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
    Li X; He J; Yu M; Zhang W; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
    Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
    Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
    Ge L; Sun Q; Xia L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator.
    Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
    Lv S; Xu W; Zhang Y; Zhang J; Dong X
    Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
    Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W
    Front Oncol; 2021; 11():656509. PubMed ID: 34178642
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Jiang F; Huang X; Yang X; Zhou H; Wang Y
    Front Oncol; 2022; 12():795971. PubMed ID: 35814368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
    Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma.
    Shan L; Zhu XL; Zhang Y; Gu GJ; Cheng X
    Transl Androl Urol; 2021 Sep; 10(9):3628-3637. PubMed ID: 34733658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
    Hu P; Shangguan J; Zhang L
    Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
    Zhai X; Yang Z; Liu X; Dong Z; Zhou D
    PeerJ; 2020; 8():e9975. PubMed ID: 33005492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
    Zhang H; Lu J; Yang Y; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Xie X; Jiang S; Li X
    Front Oncol; 2021; 11():621373. PubMed ID: 33767990
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis.
    Wang Z; Katsaros D; Shen Y; Fu Y; Canuto EM; Benedetto C; Lu L; Chu WM; Risch HA; Yu H
    PLoS One; 2015; 10(8):e0136246. PubMed ID: 26287798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
    Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer].
    Wang Z; Dang C; Yan R; Zhang H; Yuan D; Li K
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1151-1158. PubMed ID: 30377125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.